Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine

被引：0
|
作者：
Peter C. Soema
Sietske K. Rosendahl Huber
Geert-Jan Willems
Wim Jiskoot
Gideon F. A. Kersten
Jean-Pierre Amorij
机构：
[1] Intravacc (Institute for Translational Vaccinology),Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research (LACDR)
[2] Leiden University,Centre for Infectious Disease Control Netherlands
[3] National Institute for Public Health and the Environment (RIVM),undefined
来源：
Pharmaceutical Research | 2015年 / 32卷
关键词：
cross-protective; cytotoxic T-cells; influenza vaccine; peptide vaccine; virosomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1505 / 1515
页数：10
相关论文
共 50 条
  • [31] Exploring the Function of Predicted T-Cell Epitopes in Enhancing Influenza Virus Vaccine Efficacy
    Malviya J.
    Yadav S.
    Rathore P.
    Barik A.
    Mohapatra S.S.
    Sareen S.
    Sahoo B.
    Singh S.C.
    Asthana N.
    Macromolecular Symposia, 2024, 413 (02)
  • [32] Effect of homeostatic T-cell proliferation in the vaccine responsiveness against influenza in elderly people
    Herrero-Fernandez, I.
    Rosado-Sanchez, I.
    Alvarez-Rios, A. I.
    Galva, M. I.
    De Luna-Romero, M.
    Sanbonmatsu-Gamez, S.
    Perez-Ruiz, M.
    Navarro-Mari, J. M.
    Carrillo-Vico, A.
    Sanchez, B.
    Ramos, R.
    Canizares, J.
    Leal, M.
    Pacheco, Y. M.
    IMMUNITY & AGEING, 2019, 16 (1)
  • [33] Are bacterial vaccine antigens T-cell epitope depleted?
    Hailing-Brown, Mark
    Sansom, Clare E.
    Davies, Matthew
    Titball, Richard W.
    Moss, David S.
    TRENDS IN IMMUNOLOGY, 2008, 29 (08) : 374 - 379
  • [34] EPIDEMIC INFLUENZA VIRUS NUCLEOPROTEIN GENE INCORPORATED INTO VACCINE INFLUENZA VIRUS STRAIN GENOME TO OPTIMIZE SYSTEMIC AND LOCAL T-CELL IMMUNE RESPONSE AGAINST LIVE ATTENUATED INFLUENZA VACCINE
    Prokopenko, P. I.
    Stepanova, E. A.
    Matyushenko, V. A.
    Chistyakova, A. K.
    Kostromitina, A. D.
    Kotomina, T. S.
    Rak, A. Ya.
    Rubinstein, A. A.
    Kudryavtsev, I. V.
    Novitskaya, V. V.
    Rudenko, L. G.
    Isakova-Sivak, I. N.
    INFEKTSIYA I IMMUNITET, 2024, 14 (02): : 371 - 380
  • [35] Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine
    Dong, Wei
    Bhide, Yoshita
    Marsman, Sonny
    Holtrop, Marijke
    Meijerhof, Tjarko
    de Vries-Idema, Jacqueline
    de Haan, Aalzen
    Huckriede, Anke
    BIOTECHNOLOGY JOURNAL, 2018, 13 (04)
  • [36] Enhancing antibody levels and T cell activity of quadrivalent influenza vaccine by combining it with CpG HP021
    Ji, Jia
    Chen, Lei
    Wu, Zhigang
    Tang, Taoming
    Zhu, Linwei
    Zhu, Miaojin
    Chen, Yan
    Lu, Xiangyun
    Yao, Hangping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin
    Gutierrez, Andres H.
    Rapp-Gabrielson, Vicki J.
    Terry, Frances E.
    Loving, Crystal L.
    Moise, Leonard
    Martin, William D.
    De Groot, Anne S.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2017, 11 (06) : 531 - 542
  • [38] IDENTIFICATION OF K-K-RESTRICTED T-CELL EPITOPE WITHIN INFLUENZA-VIRUS NUCLEOPROTEIN
    KURODA, K
    NAKAJIMA, M
    MINAKATA, H
    HOSAKA, Y
    VIRUS RESEARCH, 1995, 38 (01) : 43 - 53
  • [39] Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion
    Keijzer, C.
    Haijema, B. J.
    Meijerhof, T.
    Voorn, P.
    de Haan, A.
    Leenhouts, K.
    van Roosmalen, M. L.
    van Eden, W.
    Broere, F.
    VACCINE, 2014, 32 (24) : 2904 - 2910
  • [40] Exploring the Potential of T-Cells for a Universal Influenza Vaccine
    Vijayanand, Sharon
    Gomes, Keegan Braz
    Gala, Rikhav P.
    Uddin, Mohammad N.
    D'Souza, Martin J.
    VACCINES, 2020, 8 (04)
12345